CYBINTRATEGIES INC. O.N.CYBINTRATEGIES INC. O.N.CYBINTRATEGIES INC. O.N.

CYBINTRATEGIES INC. O.N.

No trades
See on Supercharts
Next report date
Report period
EPS estimate
Revenue estimate
Market capitalization
‪199.26 M‬EUR
−4.90EUR
‪−53.42 M‬EUR
0.00EUR
‪18.36 M‬
Beta (1Y)

About CYBIN INC.


CEO
Douglas L. Drysdale
Headquarters
Toronto
Website
Founded
2016
FIGI
BBG00YJ7HKP9
Cybin, Inc. operates as a clinical-stage biopharmaceutical company on a mission to create safe and effective psychedelic-based therapeutics to address the large unmet need for new and innovative treatment options for people who suffer from mental health conditions. It is currently developing CYB003, a proprietary deuterated psilocybin analog for the treatment of major depressive disorder and CYB004, a proprietary deuterated DMT molecule for generalized anxiety disorder and has a research pipeline of investigational psychedelic-based compounds. The company was founded by Paul Glavine, Eric So, and John Kanakis on October 13, 2016 and is headquartered in Toronto, Canada.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange CYBINTRATEGIES INC. O.N. stocks are traded under the ticker R7E.
We've gathered analysts' opinions on CYBINTRATEGIES INC. O.N. future price: according to them, R7E price has a max estimate of 5.46 EUR and a min estimate of 0.99 EUR. Watch R7E chart and read a more detailed CYBINTRATEGIES INC. O.N. stock forecast: see what analysts think of CYBINTRATEGIES INC. O.N. and suggest that you do with its stocks.
R7E reached its all-time high on Dec 8, 2008 with the price of 12.95 EUR, and its all-time low was 4.45 EUR and was reached on Oct 10, 2008. View more price dynamics on R7E chart.
See other stocks reaching their highest and lowest prices.
Yes, you can track CYBINTRATEGIES INC. O.N. financials in yearly and quarterly reports right on TradingView.
CYBINTRATEGIES INC. O.N. is going to release the next earnings report on Nov 13, 2024. Keep track of upcoming events with our Earnings Calendar.
R7E earnings for the last quarter are −0.01 EUR per share, whereas the estimation was −0.03 EUR resulting in a 53.85% surprise. The estimated earnings for the next quarter are −0.02 EUR per share. See more details about CYBINTRATEGIES INC. O.N. earnings.
CYBINTRATEGIES INC. O.N. revenue for the last quarter amounts to 0.00 EUR, matching the estimated figure, and no changes in revenue are expected for the next quarter.
R7E net income for the last quarter is ‪−10.11 M‬ EUR, while the quarter before that showed ‪−14.60 M‬ EUR of net income which accounts for 30.75% change. Track more CYBINTRATEGIES INC. O.N. financial stats to get the full picture.
No, R7E doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, R7E shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade CYBINTRATEGIES INC. O.N. stock right from TradingView charts — choose your broker and connect to your account.